Published in World J Gastroenterol on April 21, 2013
Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma. World J Hepatol (2015) 0.78
Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients. World J Gastroenterol (2016) 0.77
Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma. World J Hepatol (2016) 0.75
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol (2009) 9.84
Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03
Liver cirrhosis. Lancet (2008) 6.11
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology (2004) 5.83
The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol (2006) 4.17
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology (2006) 2.49
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev (2012) 2.38
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol (2012) 2.25
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology (2010) 2.00
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol (2012) 1.71
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer (2011) 1.69
Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment. Am J Gastroenterol (2004) 1.63
Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol (2009) 1.50
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol (2010) 1.35
Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose. J Clin Endocrinol Metab (2007) 1.33
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood (2012) 1.20
Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology (1998) 1.16
Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan. J Diabetes Complications (2010) 1.11
The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. PLoS One (2011) 1.08
Tissue factor and cardiovascular disease: quo vadis? Circ J (2009) 1.01
Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist (2012) 0.97
Promotion of hepatocellular carcinoma by hepatitis C virus. Dig Dis (2012) 0.92
Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int (2009) 0.92
Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India (2010) 0.89
Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol (2010) 0.89
Tissue factor isoforms in cancer and coagulation: may the best isoform win. Thromb Res (2012) 0.83
Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol (2013) 0.83
Hemostatic abnormalities in cirrhosis and tumor-related portal vein thrombosis. Clin Appl Thromb Hemost (2011) 0.83
Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography. Med Oncol (2012) 0.82
Coagulation and fibrinolysis in diabetes. Semin Vasc Med (2002) 0.80
Interpretation of correlations between coagulation factors FV, FVIII and vWF in normal and type 2 diabetes mellitus patients. Pak J Biol Sci (2011) 0.79
New wrinkle between cancer and blood coagulation: metastasis and cleavage of von Willebrand factor by ADAM28. J Natl Cancer Inst (2012) 0.77
Apoptotic hepatocellular carcinoma HepG2 cells accelerate blood coagulation. Hepatol Res (2004) 0.77
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol (2012) 1.71
gammaN-crystallin and the evolution of the betagamma-crystallin superfamily in vertebrates. FEBS J (2005) 1.19
Autophagy inhibition enhances etoposide-induced cell death in human hepatoma G2 cells. Int J Mol Med (2011) 1.05
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo. J Hepatol (2011) 0.98
Cdk5 regulates cell-matrix and cell-cell adhesion in lens epithelial cells. J Cell Sci (2002) 0.96
A role for lengsin, a recruited enzyme, in terminal differentiation in the vertebrate lens. J Biol Chem (2008) 0.96
Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis. Cancer Res (2004) 0.95
Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells. Int J Mol Sci (2013) 0.94
Assessing the diagnostic accuracy of immunodiagnostic techniques in the diagnosis of schistosomiasis japonica: a meta-analysis. Parasitol Res (2010) 0.93
Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int (2009) 0.92
Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol (2010) 0.89
Platelet-derived growth factor D, tissue-specific expression in the eye, and a key role in control of lens epithelial cell proliferation. J Biol Chem (2004) 0.87
Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection. Hepatobiliary Pancreat Dis Int (2013) 0.87
Cell apoptosis and regeneration of hepatocellular carcinoma after transarterial chemoembolization. World J Gastroenterol (2004) 0.86
Retracted MicroRNA-92 promotes gastric cancer cell proliferation and invasion through targeting FXR. Tumour Biol (2014) 0.84
[Study on effects of low frequency pulse plus auricular point magnetic therapy on electrogastrogram and clinical therapeutic effect in the patient of functional dyspepsia]. Zhongguo Zhen Jiu (2007) 0.83
Retrograde gastric electrical stimulation suppresses calorie intake in obese subjects. Obesity (Silver Spring) (2013) 0.81
Expression of Bcl-2 and Bax in extrahepatic biliary tract carcinoma and dysplasia. World J Gastroenterol (2003) 0.78
[New targets for drug therapeutics: receptors for purines and pyrimidines]. Sheng Li Ke Xue Jin Zhan (2003) 0.78
Pre-operative predictive factors for intra-operative pathological lymph node metastasis in rectal cancers. Asian Pac J Cancer Prev (2013) 0.77
[Effect of baicalin on liver fatty acid binding protein in oxidative stress model in vitro]. Zhonghua Gan Zang Bing Za Zhi (2011) 0.76
Jiangrines A-F and jiangolide from an actinobacterium, Jiangella gansuensis. J Nat Prod (2014) 0.76
CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion. Tumour Biol (2014) 0.76
[Effect of Qingre Liqi Granule on clinical therapeutic efficacy, electrogastrogram and gastric emptying in patients with functional dyspepsia]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2007) 0.75
MGB-based one-step multiplex real-time PCR method for rapid detection of HPV. Cancer Biomark (2013) 0.75
[Resistance of multicellular spheroids to taxol in human ovarian cancer and its mechanism]. Ai Zheng (2003) 0.75
[Adsorption kinetic mechanism of ionic soluble dye mixture on fly ash]. Huan Jing Ke Xue (2014) 0.75
[Inducement effect of matrine on phenotype changes of rat hepatic oval cells]. Ai Zheng (2006) 0.75
[Types of primary cyclins expressed in gastric carcinoma and their relationship with clinicopathological features]. Zhonghua Zhong Liu Za Zhi (2013) 0.75
[Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol]. Zhonghua Yi Xue Za Zhi (2003) 0.75
A self-switchable Ag nanoreactor exhibiting outstanding catalytic properties. Chem Commun (Camb) (2013) 0.75
Cytokinetic analysis of cell cycle and sub-phases in MOLT-4 cells by cyclin E + A/DNA multiparameter flow cytometry. Oncol Rep (2002) 0.75
[Unscheduled expression of cyclin B1 in G(1)-phase among cultured and clinical tumor cells]. Zhonghua Zhong Liu Za Zhi (2002) 0.75